Skip to content

Research at St Andrews

A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma

Research output: Contribution to journalArticle


T J Hamblin, V Inzani, S Sadullah, F K Stevenson, P Williamson, J van der Plas, P Palmer, C R Franks

School/Research organisations


Seven patients with metastatic colorectal cancer have been treated with a regimen involving an 120-hour continuous infusion of rIL-2, 3 x 10(6) mu/m2. Entry restrictions included a Karnofsky index of greater than or equal to 80%, and a measurable lesion. One patient died of peritonitis secondary to bowel perforation at the site of the unresected tumour. One patient abandoned treatment following a pulmonary embolism during the first rIL-2 infusion. Other side effects included, pyrexia, rigors, nausea, hypotension, oliguria, weight gain, thrombocytopenia, neuropsychiatric symptoms and prerenal renal failure. Two patients have shown a greater than 50% regression in the size of their tumours and 3 have stable disease. The use of 'humanized' monoclonal antibodies together with mononuclear cells from patients receiving IL-2 infusions may provide a useful way of killing tumour cells which are resistant to lysis by LAK cells.



Original languageEnglish
Pages (from-to)163-7
Number of pages5
JournalCancer Treatment Reviews
Volume16 Suppl A
Publication statusPublished - Jun 1989

    Research areas

  • Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Colorectal Neoplasms/drug therapy, Drug Evaluation, Female, Fluorouracil/administration & dosage, Humans, Interleukin-2/administration & dosage, Liver Neoplasms/diagnosis, Male, Middle Aged, Recombinant Proteins/administration & dosage, Ultrasonography

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Non-European doctors and change in UK policy: ten thousand international medical graduates may be affected

    Trewby, P., Williams, G., Williamson, P., Barnes, E., Carr, P., Crilley, J., Foden, A., Mitchell, S. & Murphy, J., 15 Apr 2006, In : British Medical Journal. 332, 7546, p. 913-4 2 p.

    Research output: Contribution to journalLetter

  2. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease

    Williamson, P. J. & de Berker, D., Mar 2005, In : British Journal of Haematology. 128, 5, p. 582

    Research output: Contribution to journalLetter

  3. Four pedigrees of the cation-leaky hereditary stomatocytosis class presenting with pseudohyperkalaemia. Novel profile of temperature dependence of Na+–K+ leak in a xerocytic form

    Gore, D. M., Layton, M., Sinha, A. K., Williamson, P. J., Vaidya, B., Connolly, V., Mannix, P., Chetty, M. C., Nicolaou, A. & Stewart, G. W., 19 Apr 2004, In : British Journal of Haematology. 125, 4, p. 521-527 7 p.

    Research output: Contribution to journalArticle

  4. A randomised study comparing an oral regimen with intravenous for consolidation in patients over 55 years with AML in first complete remission

    Jackson, GH., Taylor, PRA., Kaczmarski, R., Mohamed, RJ., Culligan, D., Cullis, J., Littlewood, T., Summerfield, G., Williamson, P. J., Knyba, G. & Samson, D., 2000, In : British Journal of Haematology. 108, supplement

    Research output: Contribution to journalAbstract

  5. Multisystem adverse reaction to lamotrigine

    Schaub, J. E., Williamson, P. J., Barnes, E. W. & Trewby, P. N., 13 Aug 1994, In : Lancet. 344, 8920, p. 481

    Research output: Contribution to journalLetter

Related by journal

  1. New strategies for targeting the hypoxic tumour microenvironment in breast cancer

    Ward, C., Langdon, S. P., Mullen, P., Harris, A. L., Harrison, D. J., Supuran, C. T. & Kunkler, I., Apr 2013, In : Cancer Treatment Reviews. 39, 2, p. 171-179 9 p.

    Research output: Contribution to journalArticle

ID: 255030053